CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways.

Klein S, Abraham M, Bulvik B, Dery E, Weiss ID, Barashi N, Abramovitch R, Wald H, Harel Y, Olam D, Weiss L, Beider K, Eizenberg O, Wald O, Galun E, Pereg Y, Peled A

Open source

DOI: 10.1158/0008-5472.can-17-0454
Published: 2018 Mar 15
Container: Cancer research
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/0008-5472.can-17-0454,
  title = {CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways.},
  author = {Klein S and Abraham M and Bulvik B and Dery E and Weiss ID and Barashi N and Abramovitch R and Wald H and Harel Y and Olam D and Weiss L and Beider K and Eizenberg O and Wald O and Galun E and Pereg Y and Peled A},
  year = {2018},
  journal = {Cancer research},
  doi = {10.1158/0008-5472.can-17-0454},
  url = {https://doi.org/10.1158/0008-5472.can-17-0454}
}

RIS

TY  - JOUR
TI  - CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways.
AU  - Klein S
AU  - Abraham M
AU  - Bulvik B
AU  - Dery E
AU  - Weiss ID
AU  - Barashi N
AU  - Abramovitch R
AU  - Wald H
AU  - Harel Y
AU  - Olam D
AU  - Weiss L
AU  - Beider K
AU  - Eizenberg O
AU  - Wald O
AU  - Galun E
AU  - Pereg Y
AU  - Peled A
PY  - 2018
JO  - Cancer research
DO  - 10.1158/0008-5472.can-17-0454
UR  - https://doi.org/10.1158/0008-5472.can-17-0454
ER  -

APA

S, K., M, A., B, B., E, D., ID, W., N, B., R, A., H, W., Y, H., D, O., L, W., K, B., O, E., O, W., E, G., Y, P., & A, P. (2018). CXCR4 Promotes Neuroblastoma Growth and Therapeutic Resistance through miR-15a/16-1-Mediated ERK and BCL2/Cyclin D1 Pathways.. Cancer research. https://doi.org/10.1158/0008-5472.can-17-0454

Source records

pubmed · retrieved 2026-09-26T01:34:48.704Z
europe-pmc · retrieved 2026-09-26T01:34:48.721Z